{
    "2021-01-21": [
        [
            {
                "time": "2021-01-21",
                "original_text": "战投式定增被搁浅后，分拆上市正沦为资本“新的”套利通道！",
                "features": {
                    "keywords": [
                        "战投式定增",
                        "搁浅",
                        "分拆上市",
                        "资本套利"
                    ],
                    "sentiment_score": -0.6,
                    "policy_related": "true",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "综合"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            },
            {
                "time": "2021-01-21",
                "original_text": "医药生物行业：高景气CXO行业或持续高速增长 多个CXO公司发布2020业绩预告 数据超预期",
                "features": {
                    "keywords": [
                        "医药生物",
                        "CXO行业",
                        "高增长",
                        "业绩预告",
                        "数据超预期"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药生物"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}